New Surge Spreads In The U.S. As Third Vaccine Is Within Reach

The video discusses the growth of contagious coronavirus variants and their potential to increase virus spread. Health experts warn of another virus surge despite the nearing authorization of a third COVID-19 vaccine. The US leads globally in COVID-19 cases and deaths, with India and Brazil following. New variants could slow progress in reducing infections and fatalities. Johnson & Johnson's vaccine shows reduced efficacy in South Africa due to a variant, but its approval could boost US vaccination efforts. The vaccine group reported no hospitalizations or deaths, indicating a promising new vaccine candidate.

What is the main concern of health experts regarding the new coronavirus variant?

• It could lead to a new surge in cases.

• It may cause more severe symptoms.

• It is resistant to all current vaccines.

• It only affects a specific age group.

Which country is second in the number of COVID-19 cases according to the transcript?

• Brazil

• United States

• India

• Russia

What does the recent model predict about COVID-19 infections and fatalities?

• They will increase significantly.

• They will only drop in certain regions.

• They will remain the same.

• They will drop through the spring.

How did the efficacy rate of Johnson & Johnson's vaccine change in South Africa?

• It was not affected by the variant.

• It dropped to 57%.

• It remained at 72%.

• It increased to 85%.

What is a significant benefit of the new Johnson & Johnson vaccine according to the transcript?

• It is available worldwide.

• It showed no hospitalizations or deaths in the vaccine group.

• It requires two doses.

• It is cheaper than other vaccines.